14-day Premium Trial Subscription Try For FreeTry Free
$13.91
+0.350 (+2.58%)
At Close: May 02, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $12.20 $17.60 Thursday, 2nd May 2024 ENTA stock ended at $13.91. This is 2.58% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 4.19% from a day low at $13.38 to a day high of $13.94.
90 days $11.01 $17.80
52 weeks $8.08 $37.14

Historical Enanta Pharmaceuticals prices

Date Open High Low Close Volume
Jun 17, 2020 $51.13 $51.86 $50.13 $50.22 89 443
Jun 16, 2020 $51.17 $51.75 $49.69 $51.29 89 666
Jun 15, 2020 $47.93 $50.90 $47.48 $50.04 109 430
Jun 12, 2020 $49.33 $49.67 $46.90 $48.52 164 258
Jun 11, 2020 $50.43 $50.81 $48.20 $48.24 170 522
Jun 10, 2020 $52.38 $52.49 $50.54 $51.18 82 711
Jun 09, 2020 $51.45 $53.06 $50.77 $52.18 108 189
Jun 08, 2020 $51.07 $51.86 $50.46 $51.78 110 617
Jun 05, 2020 $51.35 $52.05 $50.53 $50.72 121 752
Jun 04, 2020 $50.36 $52.00 $48.99 $50.07 128 417
Jun 03, 2020 $51.03 $53.22 $50.33 $50.95 152 667
Jun 02, 2020 $50.46 $50.59 $49.20 $50.41 274 866
Jun 01, 2020 $51.34 $53.18 $50.02 $50.67 189 333
May 29, 2020 $50.77 $51.78 $48.19 $51.49 258 202
May 28, 2020 $50.82 $52.91 $50.65 $51.60 132 822
May 27, 2020 $55.44 $55.44 $50.45 $50.71 170 394
May 26, 2020 $56.50 $56.50 $54.86 $54.93 179 067
May 22, 2020 $54.93 $55.87 $54.50 $55.30 54 472
May 21, 2020 $56.10 $56.10 $54.55 $55.00 79 767
May 20, 2020 $54.43 $56.57 $54.43 $56.09 105 043
May 19, 2020 $58.03 $58.59 $54.31 $54.39 137 673
May 18, 2020 $56.53 $58.36 $55.81 $57.58 269 450
May 15, 2020 $53.59 $56.28 $53.48 $55.20 151 724
May 14, 2020 $53.18 $53.89 $52.44 $53.68 128 250
May 13, 2020 $53.38 $56.38 $52.90 $54.15 187 095
Click to get the best stock tips daily for free!

About Enanta Pharmaceuticals

Enanta Pharmaceuticals Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A pro... ENTA Profile

Golden Star

Ticker Date Change Price
HRB Apr 29 1.00% $47.23
LYG Apr 29 0.391% $2.56
ORA Apr 29 1.95% $64.48
ETSY Apr 26 3.43% $67.43
DHT Apr 24 0.98% $11.28
LPLA Apr 19 1.10% $262.59
MLI Apr 19 7.29% $52.28
PFLT Apr 18 1.33% $11.25
DOOR Apr 18 0.94% $131.39
OCSL Apr 17 0.360% $19.43
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT